Study Confirms Dinutuximab Extends Life for Children with High-Risk Neuroblastoma - Cancer Currents Blog

The latest from the NCI Cancer Currents blog

Having trouble viewing this email? View it as a Web page.

You are subscribed to Cancer Currents: An NCI Cancer Research Blog from the National Cancer Institute. Recent posts are listed below.     Study Confirms Dinutuximab Extends Life for Children with High-Risk Neuroblastoma 09/06/2022 Researchers have confirmed that the immunotherapy drug dinutuximab (Unituxin) can help children with high-risk neuroblastoma live longer. The finding is based on a trial of nearly 1,200 children with the disease.

Stay Connected with the National Cancer Institute
Chat with us: LiveHelp       Call us: 1-800-4-CANCER (1-800-422-6237) SUBSCRIBER SERVICES: Manage Subscriptions  |  Help

 

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892

American Heart Association: Data from Israel: myocarditis after COVID-19 vaccines remain rare, highest risk in young males

Hello HCIS,

Thank you for your interest in news from the American Heart Association. Click below to see the latest updates:

September 06, 2022
Data from Israel: myocarditis after COVID-19 vaccines remain rare, highest risk in young males

https://newsroom.heart.org/news/data-from-israel-myocarditis-after-covid-19-vaccines-remain-rare-highest-risk-in-young-males

---

Click below to unsubscribe from American Heart Association email alerts.

Unsubscribe

American Heart Association: High blood pressure awareness, control improved with better access to primary health care

Hello HCIS,

Thank you for your interest in news from the American Heart Association. Click below to see the latest updates:

September 06, 2022
High blood pressure awareness, control improved with better access to primary health care

https://newsroom.heart.org/news/high-blood-pressure-awareness-control-improved-with-better-access-to-primary-health-care

---

Click below to unsubscribe from American Heart Association email alerts.

Unsubscribe

Research To Improve Pain Management

Pain is the most common reason for seeking medical care. It is also a common reason why people turn to complementary and integrative health

Click here to view in browser. Research To Improve Pain Management Pain is the most common reason for seeking medical care. It is also a common reason why people turn to complementary and integrative health approaches—which is why pain is a top research priority for the National Center for Complementary and Integrative Health. Since 2017, we've been partnering with other Institutes and Centers at the National Institutes of Health (NIH), as well as the Department of Defense and the Department of Veterans Affairs, to support the Pain Management Collaboratory, which is conducting large-scale studies of nondrug approaches for pain management in the military and veterans' health care systems. As part of the Helping to End Addiction Long-term® Initiative, or NIH HEAL Initiative®, we're leading research in real-world health care systems to evaluate the effectiveness of acupuncture, physical therapy, mindfulness-based stress reduction, and other nondrug treatments in managing various types of pain and reducing the need for opioid drugs. We're also leading the NIH Pain Research Center, which brings together researchers from different parts of NIH to conduct research to better understand the mechanisms of different kinds of pain, find out how well nonopioid treatments work, and predict individual patients' responses to pain therapies.   Find out more

Connect with NCCIH SUBSCRIBER SERVICES: Manage Preferences/Unsubscribe | Subscription Help

 

---

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Center for Complementary and Integrative Health · 9000 Rockville Pike · Bethesda, MD 20892

The Panel on Antiretroviral Guidelines for Adults and Adolescents updated the following section

View as a webpage  /  Share September 1, 2022 Updates to the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV The Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) updated the following section of the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Highlights from the section are summarized below: Drug–Drug Interactions Tables The Panel updated the Drug–Drug Interactions tables (Tables 24a–f) with guidance on the interaction potentials between antiretroviral drugs and antiviral drugs (brincidofovir, cidofovir, or tecovirimat) that are currently being used to treat monkeypox. For a complete list of updates, please see What's New in the Guidelines. To view or download the guidelines, please see the Adult and Adolescent ARV Guidelines section of Clinical Info's website. The guidelines tables and recommendations can also be downloaded as separate PDF files. Clinical Info welcomes your feedback on the latest revisions to the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Please send your comments with the subject line "Adult and Adolescent ARV Guidelines" to HIVinfo@NIH.gov by September 22, 2022. Stay Connected with HIVinfo:       SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

 

---

You are subscribed as myhcistech.healthnews360@blogger.com.  Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit the GovDelivery Subscriber Help Center at https://insights.govdelivery.com/Communications/Subscriber_Help_Center.

This service is provided in collaboration with NIH's Office of AIDS Research and HHS Office of Infectious Disease and HIV/AIDS Policy/HIV.gov.

---

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: HIVinfo · 8600 Rockville Pike · Bethesda, MD 20894 · 888-346-3656

September 1, 2022 Retirement symposium for Carmen Brewer set for September 30 On Friday, September 30, 2022, the National Institute on Deafness and Other Communication Disorders (NIDCD) will hold a symposium honoring Carmen C. Brewer, Ph.D., chief research audiologist of the NIDCD Audiology Unit. The half-day symposium will highlight the impact Dr. Brewer has had on research at the NIH and the contributions she has made to the audiology field. Dr. Brewer will retire in October. The virtual symposium will be open to all. Live captioning will be available. Limited in-person attendance (RSVP required) is available for NIH staff only. Read more » Health Information Hearing, ear infections, etc. Balance Taste and smell Voice, speech, and language Popular Topics Do you need a hearing test? Ear infections Tinnitus Stuttering NIDCD now offers an easy way for you to get trusted, up-to-date content for your website. Learn more about content syndication >> The NIDCD, part of the National Institutes of Health, supports and conducts research and research training on the normal and disordered processes of hearing, balance, taste, smell, voice, speech, and language and provides health information, based upon scientific discovery, to the public. For more information about NIDCD programs, see our website at www.nidcd.nih.gov. NIH...Turning Discovery Into Health® U.S. Department of Health and Human Services (HHS)  National Institutes of Health (NIH)

 

---

Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit https://insights.govdelivery.com/Communications/Subscriber_Help_Center.

---

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud, on behalf of: National Institute on Deafness and Other Communication Disorders · 31 Center Drive, MSC 2320 ·  Bethesda, MD USA 20892-2320

Important: UPCOMING CMS EMAIL SERVICES TRANSITION - CMS Email Services Transition over Labor Day Weekend

View in browser | Distributed by Center for Medicaid and CHIP Services (CMCS) The Centers for Medicare & Medicaid Services (CMS) will be undergoing an email transition over the Labor Day weekend (late Friday, September 2, to early Tuesday, September 6).  CMS users will not be able to access or receive email during the transition.   If you send an email to CMS during this time, you will receive an error message that the CMS users account does not exist and your email will not be received. We are asking stakeholders to hold emails during this time period. We apologize for any inconvenience.   Stay connected with Medicaid.gov and CMS: Modify/Update Subscriber Preferences  |  Unsubscribe  |  Contact Us   Questions or problems? Please contact subscriberhelp.govdelivery.com. This e-mail was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of the Centers for Medicare & Medicaid Services (410-786-5473) · 7500 Security Boulevard · Baltimore MD 21244